Clinical trial
Thromboprophylaxis in the Morbidly Obese With Weight Based Dosing of Fondaparinux: A Pharmacodynamic Study
NCT00346879 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thromboprophylaxis in the Morbidly Obese With Weight Based Dosing of Fondaparinux: A Pharmacodynamic Study
- Lead sponsor
- Indiana University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- August 31, 2006
- Completion date
- January 31, 2009
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
morbid obesity